Pain Neuroscience: Central Sensitization, the Placebo Effect, and Modulation Strategies
The traditional biomedical pain model: tissue damage → peripheral nociceptors activate → spinal cord → brain pain regions, with pain intensity proportional to injury. This simple model is challenged by: phantom limb pain (amputees feeling intense pain in missing limbs with no peripheral tissue damage); placebo surgery (in multiple RCTs, sham surgery equals real surgery for pain relief); identical tissue damage producing vastly different pain experiences across different contexts, emotional states, and beliefs.
## Central Sensitization: The Neural Mechanism of Chronic Pain
**Central Sensitization**: in chronic pain patients, the central nervous system (spinal cord and brain) systematically changes in pain signal processing — lowered pain thresholds (smaller stimuli trigger stronger pain); normal touch or movement stimuli experienced as pain (Allodynia); pain spreading beyond the original injury area. Central sensitization explains why fibromyalgia, chronic back pain (with structural causes excluded), and Complex Regional Pain Syndrome (CRPS) patients have genuine neurological pain despite no identifiable peripheral damage.
**Placebo analgesia neural mechanism**: placebo pain relief has real neurobiological basis — receiving a placebo painkiller while expecting its effect triggers endogenous opioid release, blockable by opioid antagonists (naloxone). The placebo effect isn’t “imagined” — it’s activation of the brain’s own pain modulation system.
**Pain Reprocessing Therapy (PRT)**: psychological intervention targeting central sensitization, reducing threatening interpretation of pain signals (“this is a nervous system false alarm, not actual damage”). [Ashar et al. 2021 RCT in JAMA Psychiatry](https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2784694) showed PRT significantly effective for chronic back pain (73% of PRT group pain-free or nearly so vs. 27% placebo).
